Cargando…
External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population
BACKGROUND & AIMS: The Toronto hepatocellular carcinoma (HCC) risk index (THRI) is a predictive model to determine the risk of HCC in patients with cirrhosis. This study aimed to externally validate the THRI in a Swedish setting to investigate whether it could identify patients not requiring HCC...
Autores principales: | Åström, Hanne, Ndegwa, Nelson, Hagström, Hannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476346/ https://www.ncbi.nlm.nih.gov/pubmed/34611618 http://dx.doi.org/10.1016/j.jhepr.2021.100343 |
Ejemplares similares
-
Validation of the Toronto hepatocellular carcinoma risk index for patients with cirrhosis in China: a retrospective cohort study
por: Zhang, Huixian, et al.
Publicado: (2019) -
The risk of hepatocellular carcinoma in cirrhosis differs by etiology, age and sex: A Swedish nationwide population‐based cohort study
por: Bengtsson, Bonnie, et al.
Publicado: (2022) -
Validation of an obstetric comorbidity index in an external population
por: Metcalfe, A, et al.
Publicado: (2015) -
External review and validation of the Swedish national inpatient register
por: Ludvigsson, Jonas F, et al.
Publicado: (2011) -
A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)
por: Pinato, D J, et al.
Publicado: (2012)